Table 3.
Adjusted Analyses of Mortality, LOS, and Time to Chemotherapy by Day of Admissiona
| Variable | Mortality in First Admission, OR (95% CI) | LOS Attributable to Variable, Days (95% CI) | Time to Chemotherapy Attributable to Variable, Days (95% CI) |
|---|---|---|---|
| Day of admission | |||
| Weekend | 1.0 (0.8 to 1.6) | 1.4 (0.7 to 2.l)b | 0.4 (0.3 to 0.5)b |
| Weekday | … | … | … |
| Disease | |||
| AML | 3.2 (2.1 to 4.9)b | 22.7 (21.9 to 23.6)b | 0.5 (0.3 to 0.6)b |
| ALL | … | … | … |
| Severely ill within first 2 d of admission | 5.4 (3.2 to 9.0)b | 6.8 (5.4 to 8.3)b | −0.6 (−0.8 to −0.4)b |
| Hospital-level factors | |||
| Presence of fellowship program | 1.3 (0.7 to 2.8) | 0.8 (0.1 to 1.5)c | 0.3 (0.2 to 0.4)b |
| Magnet status | 0.7 (0.5 to 1.1) | −0.2 (−0.8 to −0.4) | −0.3(−0.4 to −0.2)b |
| % of public payers | 1.0 (1.0 to 1.0) | 0 (0 to 0)d | 0 (0 to 0) |
| No. of oncology admissions | 1.0 (1.0 to 1.0) | 0 (0 to 0) | 0 (0 to 0)b |
Abbreviations: ALL, acute lymphoid leukemia; AML, acute myeloid leukemia; ellipses, comparator group; LOS, length of stay; OR, odds ratio.
a
Adjusted for demographics (sex, age, race/ethnicity, and insurance[not shown]), severity of illness, and hospital-level factors (presence of a fellowship program in year of admission, Magnet status in hospital of admission, percentage of public payers per admissions per year, and number of oncology admissions per year).
b
P < .001.
c
P < .05.
d
P < .01.